PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
26-Feb-2026 Vicore Pharma to Present at Upcoming Investor Conferences ACCESS Newswire
26-Feb-2026 BioInvent International AB: Year-End Report January 1 - December 31, 2025 ACCESS Newswire
26-Feb-2026 Invitation to Presentation of BioInvent's Year-End Report 2025 ACCESS Newswire
26-Feb-2026 FDA Approves NUMELVI™ (atinvicitinib tablets) for Dogs from Merck Animal Health – The First and Only Second-Generation Janus Kinase (JAK) Inhibitor for the Control of Pruritus Associated with Allergic Dermatitis Businesswire
26-Feb-2026 Thermo Fisher Scientific Increases Quarterly Dividend Businesswire
26-Feb-2026 ON24 Announces Fourth Quarter and Full Year 2025 Financial Results Businesswire
26-Feb-2026 GoodRx Reports Fourth Quarter and Full Year 2025 Results Businesswire
26-Feb-2026 Schrödinger Reports Fourth Quarter and Full-Year 2025 Financial Results Businesswire
26-Feb-2026 AdaptHealth Corp. to Participate in Upcoming Investor Conferences Businesswire
26-Feb-2026 Sarepta Therapeutics Announces Fourth Quarter and Full-Year 2025 Financial Results and Recent Corporate Developments Businesswire
26-Feb-2026 Arcus Biosciences Reports Fourth-Quarter and Full-Year 2025 Financial Results and Provides a Pipeline Update Businesswire
26-Feb-2026 Innoviva Reports Fourth Quarter and Full Year 2025 Financial Results; Highlights Recent Company Progress Businesswire
26-Feb-2026 TriSalus Life Sciences to Host Fourth Quarter 2025 Financial Results Conference Call Businesswire
25-Feb-2026 Portal Innovations Taps Seasoned Executive to Lead Its Newest Powered by Portal Site at the New Jersey Innovation Hub Businesswire
25-Feb-2026 Gilead’s Single-Tablet Regimen of Bictegravir and Lenacapavir Maintained Virological Suppression in People With HIV Who Switched Antiretroviral Therapy Businesswire
25-Feb-2026 Merck Announces Late-Breaking Data from Three Phase 3 Trials Evaluating Doravirine/Islatravir (DOR/ISL), an Investigational, Once-Daily, Two-Drug Regimen for the Treatment of Adults Living with HIV-1 at CROI 2026 Businesswire
25-Feb-2026 Brainlab and Precision NeuroMed Announce Strategic Partnership to Standardize and Scale Precision Drug Delivery to the Brain Businesswire
25-Feb-2026 ELRIG Appoints Dr Kelly Gray and Dr Elaine Duncan to its Board ELRIG
25-Feb-2026 Study Confirms Safety of Using Theranica’s Nerivio REN Wearable for Treatment of Migraine Simultaneously with Contemporary Continuous Glucose Monitoring (CGM) Devices Theranica’s Nerivio
25-Feb-2026 Catalyst OrthoScience Announces FDA 510(k) Clearance of Archer® Patient-Specific Instrumentation for Shoulder Arthroplasty Businesswire